Dose-dense (dd) doxorubicin-cyclophosphamide (AC) X 4 and short-term changes in left ventricular ejection fraction (LVEF) alone or with bevacizumab (B) in patients (pts) with early stage breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback